SUPREMACIE NX JOUR- ensulizole, homosalate, octinoxate, and oxybenzone cream 
Ventura Corporation, LTDA

----------

Suprémacie Nx Tour Replenishing Treatment Daytime Face Cream SPF 15 Normal to Dry Skin

ACTIVE INGREDIENTS:ENSULIZOLE 2.0%, HOMOSALATE 2.0%, OCTINOXATE 7.0%, OXYBENZONE 4.0%.

WARNINGS:For external use only. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if irritation develops and lasts.

USES:Sun Protection Factor 15. Helps prevent sunburn.

DIRECTIONS:Apply evenly before sun exposure and as needed.

KEEP OUT OF REACH OF CHILDREN

PURPOSE

Inactive ingredients

PRINCIPAL DISPLAY PANEL - 50 g jar

L'BEL
PARIS

SUPREMACIE NX JOUR

traitement reconstituant crème
de jour pour le visage fps 15
tratamiento reconstituyente crema
facial de día fps 15
replenishing treatment daytime face
cream spf 15

peau normale à sèche / normal to dry
skin / cutis normal a seco

50 g e (1.7 oz.)

PRINCIPAL DISPLAY PANEL - 50 g jar
SUPREMACIE  NX JOUR
ensulizole, homosalate, octinoxate, and oxybenzone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:13537-261
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ENSULIZOLE (UNII: 9YQ9DI1W42) (ENSULIZOLE - UNII:9YQ9DI1W42) ENSULIZOLE0.001 g  in 5 g
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE0.001 g  in 5 g
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE0.00375 g  in 5 g
OXYBENZONE (UNII: 95OOS7VE0Y) (OXYBENZONE - UNII:95OOS7VE0Y) OXYBENZONE0.002 g  in 5 g
Inactive Ingredients
Ingredient NameStrength
GLYCERIN (UNII: PDC6A3C0OX)  
TRIETHANOLAMINE (UNII: 9O3K93S3TK)  
WATER (UNII: 059QF0KO0R)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
CYCLOPENTASILOXANE (UNII: 0THT5PCI0R)  
CYCLOHEXASILOXANE (UNII: XHK3U310BA)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:13537-261-641 in 1 BOX02/19/201012/31/2021
1NDC:13537-261-615 g in 1 TUBE; Type 0: Not a Combination Product
2NDC:13537-261-651 in 1 JAR02/19/201012/31/2021
2NDC:13537-261-6250 g in 1 JAR; Type 0: Not a Combination Product
3NDC:13537-261-631 g in 1 PACKET; Type 0: Not a Combination Product02/19/201012/31/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02002/19/201012/31/2021
Labeler - Ventura Corporation, LTDA (602751344)
Establishment
NameAddressID/FEIBusiness Operations
BEL STAR SA880160197manufacture(13537-261)

Revised: 5/2025
Document Id: 34178401-0ef8-512f-e063-6294a90ab88a
Set id: fcd21129-4cb4-4cfb-9865-3cfde69eac0b
Version: 2
Effective Time: 20250501
 
Ventura Corporation, LTDA